Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies

The enormous sequence diversity between human immunodeficiency virus type 1 (HIV-1) strains poses a major roadblock for generating a broadly protective vaccine. Many experimental HIV-1 vaccine efforts are therefore aimed at eliciting broadly neutralizing antibodies (bNAbs) that are capable of neutra...

Descrizione completa

Dettagli Bibliografici
Autori principali: Mitch Brinkkemper, Kwinten Sliepen
Natura: Articolo
Lingua:English
Pubblicazione: MDPI AG 2019-07-01
Serie:Vaccines
Soggetti:
Accesso online:https://www.mdpi.com/2076-393X/7/3/76